Herve Sartelet

Summary

Country: Canada

Publications

  1. doi request reprint CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
    Herve Sartelet
    Department of Pathology and Cytogenetics, CHU Sainte Justine, Université de Montreal Research Center, CHU Sainte Justine, Montreal, QC, Canada
    Histopathology 60:1144-55. 2012
  2. doi request reprint AKT pathway in neuroblastoma and its therapeutic implication
    Herve Sartelet
    Faculty of Medicine, University of Montreal and Pediatric Pathologist, Department of Pathology, CHU Sainte Justine, 3175, Cote Sainte Catherine, Montreal, Quebec, H3T 1C5, Canada
    Expert Rev Anticancer Ther 8:757-69. 2008
  3. doi request reprint High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastoma
    Herve Sartelet
    Department of Pathology, CHU Sainte Justine Montreal, Montreal, Quebec, Canada
    Histopathology 56:607-16. 2010
  4. ncbi request reprint Expression of erythropoietin and its receptor in neuroblastomas
    Herve Sartelet
    Department of Pathology, Sainte Justine University Hospital Center, University of Montreal, Montreal, Quebec, Canada
    Cancer 110:1096-106. 2007
  5. doi request reprint Expression of nicotinic receptors in normal and tumoral pulmonary neuroendocrine cells (PNEC)
    Herve Sartelet
    Department of Pathology, CHU Sainte Justine, Université de Montréal 3175, Cote Sainte Catherine, Montreal, QC, Canada H3T1C5
    Pathol Res Pract 204:891-8. 2008
  6. doi request reprint Collapsing glomerulopathy in Galloway-Mowat syndrome: a case report and review of the literature
    Herve Sartelet
    Pol Bouin Laboratory, University of Reims, CHU Reims, Reims, France
    Pathol Res Pract 204:401-6. 2008
  7. doi request reprint Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1
    Herve Sartelet
    UPRES EA3535, University of Paris South, Institut Gustave Roussy, 94805 Villejuif, France
    Hum Pathol 42:1727-39. 2011
  8. pmc Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression
    Carine Nyalendo
    Laboratoire de Medecine Moleculaire, Universite du Quebec a Montreal, C, P, 8888, Succ, Centreville, Montreal, Quebec H3C 3P8, Canada
    BMC Cancer 9:422. 2009
  9. doi request reprint Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling
    Borhane Annabi
    Laboratoire d Oncologie Moleculaire, Departement de Chimie, Universite du Quebec a Montreal, Montreal, Quebec, Canada
    Mol Carcinog 48:910-9. 2009
  10. ncbi request reprint Inhibition of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice
    Carine Nyalendo
    Laboratoire de Medecine Moleculaire, Universite du Quebec a Montreal, C P 8888, Succ Centre Ville, Montreal, Quebec H3C 3P8, Canada
    Anticancer Res 30:1887-95. 2010

Collaborators

Detail Information

Publications30

  1. doi request reprint CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
    Herve Sartelet
    Department of Pathology and Cytogenetics, CHU Sainte Justine, Université de Montreal Research Center, CHU Sainte Justine, Montreal, QC, Canada
    Histopathology 60:1144-55. 2012
    ....
  2. doi request reprint AKT pathway in neuroblastoma and its therapeutic implication
    Herve Sartelet
    Faculty of Medicine, University of Montreal and Pediatric Pathologist, Department of Pathology, CHU Sainte Justine, 3175, Cote Sainte Catherine, Montreal, Quebec, H3T 1C5, Canada
    Expert Rev Anticancer Ther 8:757-69. 2008
    ..Drugs with a direct or indirect inhibitory effect on the AKT pathway, used alone or in combination with other drugs, seem to hold great promise as a new therapeutic modality in neuroblastoma...
  3. doi request reprint High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastoma
    Herve Sartelet
    Department of Pathology, CHU Sainte Justine Montreal, Montreal, Quebec, Canada
    Histopathology 56:607-16. 2010
    ....
  4. ncbi request reprint Expression of erythropoietin and its receptor in neuroblastomas
    Herve Sartelet
    Department of Pathology, Sainte Justine University Hospital Center, University of Montreal, Montreal, Quebec, Canada
    Cancer 110:1096-106. 2007
    ..The objective of the current study was to evaluate expression levels of Epo and EpoR in NB and in normal tissues and their effects on the proliferation of tumor cells...
  5. doi request reprint Expression of nicotinic receptors in normal and tumoral pulmonary neuroendocrine cells (PNEC)
    Herve Sartelet
    Department of Pathology, CHU Sainte Justine, Université de Montréal 3175, Cote Sainte Catherine, Montreal, QC, Canada H3T1C5
    Pathol Res Pract 204:891-8. 2008
    ..009). Thus, alpha7 subunit nicotinic receptor in a context of chronic nicotinic intoxication seems to be associated with an aggressive phenotype in the spectrum of the NE tumors...
  6. doi request reprint Collapsing glomerulopathy in Galloway-Mowat syndrome: a case report and review of the literature
    Herve Sartelet
    Pol Bouin Laboratory, University of Reims, CHU Reims, Reims, France
    Pathol Res Pract 204:401-6. 2008
    ..The majority of the glomeruli were sclerotic. We report the first case of GMS associated with a collapsing glomerulopathy...
  7. doi request reprint Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1
    Herve Sartelet
    UPRES EA3535, University of Paris South, Institut Gustave Roussy, 94805 Villejuif, France
    Hum Pathol 42:1727-39. 2011
    ..Thioredoxin 1 is a potential target for therapeutic intervention...
  8. pmc Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression
    Carine Nyalendo
    Laboratoire de Medecine Moleculaire, Universite du Quebec a Montreal, C, P, 8888, Succ, Centreville, Montreal, Quebec H3C 3P8, Canada
    BMC Cancer 9:422. 2009
    ..Based on our recent demonstration that MT1-MMP phosphorylation is involved in the growth of fibrosarcoma tumors, we examined the potential role of phosphorylated MT1-MMP in neuroblastoma progression...
  9. doi request reprint Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling
    Borhane Annabi
    Laboratoire d Oncologie Moleculaire, Departement de Chimie, Universite du Quebec a Montreal, Montreal, Quebec, Canada
    Mol Carcinog 48:910-9. 2009
    ..The emergence of lead compounds targeting the stem cell niche and S1P/LPA signaling in CD133(+) cancer cells is warranted...
  10. ncbi request reprint Inhibition of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice
    Carine Nyalendo
    Laboratoire de Medecine Moleculaire, Universite du Quebec a Montreal, C P 8888, Succ Centre Ville, Montreal, Quebec H3C 3P8, Canada
    Anticancer Res 30:1887-95. 2010
    ..Overall, these findings suggest that inhibition of MT1-MMP tyrosine phosphorylation may represent an attractive strategy for the development of novel anticancer drugs...
  11. doi request reprint Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis
    Rola Al Dhaybi
    Division of Dermatology, CHU Sainte Justine, University of Montreal, Montreal, QC, Canada
    Mod Pathol 23:376-80. 2010
    ..CD133(+) cancer stem cell expression in childhood malignant melanoma might correlate with lymph node and/or visceral metastasis and may have a low proliferative Ki-67 index that might explain their chemoresistance...
  12. doi request reprint Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma
    Sonia Cournoyer
    Centre de Recherche CHU Sainte Justine, Montreal, QC, Canada
    Genes Chromosomes Cancer 51:792-804. 2012
    ..Our results show that CD133high NB cells have TICs properties and present different genotyping characteristics compared to CD133low cells. Our findings reveal insights into new therapeutic targets in NB TICs...
  13. ncbi request reprint Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys
    Herve Sartelet
    Pol Bouin Laboratory, University of Reims, Paris, France
    Am J Transplant 5:2441-7. 2005
    ..01). The potential role of sirolimus-induced downregulation of VEGF as a predisposing factor to the development of TMA is discussed...
  14. ncbi request reprint Presence of autoantibodies against tubular and uveal cells in a patient with tubulointerstitial nephritis and uveitis (TINU) syndrome
    Lynda Abed
    Department of Pathology, CHU Sainte Justine, University of Montreal, 3175, Côte Sainte Catherine Montréal, Quebec, H3T 1C5, Canada
    Nephrol Dial Transplant 23:1452-5. 2008
  15. ncbi request reprint Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice
    Herve Sartelet
    CHU Sainte Justine Research Center, Center de Cancérologie Charles Bruneau, Montreal, QC, Canada
    In Vivo 26:19-29. 2012
    ..These results clearly demonstrate the higher tumorigenic and metastatic potential of NB cells in NSG mice. Therefore, this xenograft NB model should prove useful in testing the efficacy of new therapeutic approaches for NB...
  16. doi request reprint c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration
    Mathieu Provençal
    Laboratoire de Medecine Moleculaire, Universite du Quebec a Montreal, C P 8888, Succursale Center Ville, Montreal, Quebec, Canada
    Carcinogenesis 30:1089-96. 2009
    ..In addition, TF-mediated non-hemostatic functions, such as migration toward FVIIa, may also play a central role in MB aggressiveness...
  17. pmc LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion
    Gwenn Perrot
    Universite de Reims Champagne Ardenne, Unité MEDyC, CNRS FRE 3481, Laboratoire SiRMa, Campus Moulin de la Housse, Reims, France
    Mol Cell Biol 32:3293-307. 2012
    ..Altogether, our data shed light on the LRP-1-mediated internalization of CD44 that appeared critical to define the adhesive properties of tumor cells...
  18. doi request reprint Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice
    Carine Nyalendo
    Laboratoire de Medecine Moleculaire, Centre de cancérologie Charles Bruneau, CHU Sainte Justine, 3175 Chemin Cote Ste Catherine, Montreal, Quebec, Canada
    Carcinogenesis 29:1655-64. 2008
    ....
  19. doi request reprint The dietary flavones apigenin and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-beta phosphorylation
    Sylvie Lamy
    Laboratoire de Medecine Moleculaire, Hôpital Ste Justine Université du Québec à Montréal, Quebec, Canada
    Cancer Prev Res (Phila) 1:452-9. 2008
    ..Overall, these results identify apigenin and luteolin as dietary-derived inhibitors of PDGFR-beta activity and suggest that this inhibitory effect may contribute to the chemopreventive properties of these molecules...
  20. doi request reprint Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype
    Borhane Annabi
    Laboratoire de Medecine Moleculaire, Universite du Quebec a Montreal, CP 8888, Succursale Centre Ville, Montreal, Quebec, Canada H3C 3P8
    Mol Cancer Res 6:907-16. 2008
    ..Our study suggests that MMP-9 or MT1-MMP targeting may reduce the formation of brain tumor stem cells...
  21. pmc Elastin peptides signaling relies on neuraminidase-1-dependent lactosylceramide generation
    Anthony Rusciani
    Laboratoire Signalisation et Récepteurs Matriciels SiRMa, UMR CNRS 6237, Universite de Reims Champagne Ardenne, Faculte des Sciences, Reims, France
    PLoS ONE 5:e14010. 2010
    ..As a consequence, we propose that LacCer is an early messenger for this receptor...
  22. doi request reprint Paratesticular rhabdomyosarcoma presenting as thickening of the tunica vaginalis
    Francoise Rypens
    Department of Medical Imaging, CHU Sainte Justine, Montreal H3T 1C5, Canada
    Pediatr Radiol 39:1010-2. 2009
    ..The tumor presented as thickening of the tunica vaginalis. Atypical US appearance and discordance with clinical features caused suspicion of a tumoral process, allowing early diagnosis and treatment...
  23. ncbi request reprint Mesangiolipidosis in Alagille syndrome--relationship with apolipoprotein A-I
    Genevieve Benoit
    Division of Nephrology, Department of Pediatrics, CHU Sainte Justine, 3175 chemin de la Cote Sainte Catherine, Montreal, Quebec, Canada, H3T 1C5
    Nephrol Dial Transplant 22:2072-5. 2007
  24. doi request reprint Extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation associated with EWSR1(Ewing sarcoma breakpoint region 1)/FLI1 translocation without prior chemotherapy
    K Vali
    Department of Surgery, Hopital Sainte Justine, Montreal, Quebec, Canada
    Hum Pathol 43:1772-6. 2012
    ..This is the first case, documented by molecular studies, in which neuroblastoma-like differentiation has been noted in primitive neuroectodermal tumor/Ewing sarcoma without prior chemotherapy...
  25. ncbi request reprint Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR
    Herve Sartelet
    Department of Pathology, CHU de Grenoble, 38043 Grenoble Cedex 09, France
    J Pathol 198:83-91. 2002
    ..001) and could detect heterogeneous amplification. FISH could therefore become an important complementary procedure in assessing prognosis in neuroblastomas...
  26. doi request reprint Renal granuloma and immunoglobulin M-complex glomerulonephritis: a case of common variable immunodeficiency?
    Genevieve Benoit
    Department of Pediatrics, CHU Sainte Justine, Universite de Montreal, 3175 chemin de la Cote Sainte Catherine, Montreal, Quebec, Canada
    Pediatr Nephrol 24:601-4. 2009
    ..CVID must be included in the differential diagnosis of renal granuloma and should be differentiated from sarcoidosis to ensure appropriate therapy...
  27. doi request reprint De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma
    Geraldine Rath
    Universite de Reims Champagne Ardenne, Laboratoire SiRMa, CNRS UMR MEDyC 6237, Faculte des Sciences, Reims, France
    Int J Biochem Cell Biol 41:1165-72. 2009
    ....
  28. ncbi request reprint Acute megakaryoblastic leukemia in an infant mimicking polycystic kidney disease
    Sylvie Daliphard
    Department of Hematology, CHU Reims, France
    Med Pediatr Oncol 38:53-4. 2002
  29. doi request reprint Leydig cell tumors in children: contrasting clinical, hormonal, anatomical, and molecular characteristics in boys and girls
    Patricia Olivier
    Endocrinology Service and Research Center, CHU Sainte Justine and Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
    J Pediatr 161:1147-52. 2012
    ..To analyze the clinical, hormonal, anatomical, and molecular characteristics of Leydig cell tumors, a very rare cause of progressive hyperandrogenism in children...
  30. doi request reprint Transport characteristics of a novel peptide platform for CNS therapeutics
    Yanick Bertrand
    Laboratoire de Medecine Moleculaire, Universite du Quebec a Montreal, Montreal, Canada Angiochem, Inc, Montreal, Canada
    J Cell Mol Med 14:2827-39. 2010
    ..The primary sequence and charge of Angiopep-2 were crucial for its passage across the BBB. Overall, the results demonstrate the significant potential of this platform for the development of novel neurotherapeutics...